KARIN JOOSS was named chief scientific officer of Gritstone Oncology. Jooss previously served as head of Cancer Immunotherapeutics and Immunopharmacology at Pfizer for seven years. Mojca Skoberne also joined the company as senior director of immunology. Skoberne most recently served as program lead at Genocea Biosciences, a company that identifies targets of T cell responses....
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
